For example, clinical trials show the following average weight loss results over 72 weeks: Saxenda : Around 8% of body weight Wegovy : Nearly 15% Zepbound : Up to 21% But its not just about weight loss
Diabetic gastroparesis
In 2023, after a 40 percent rebate, the SHP spent $102.3 million on GLP-1s for weight loss, approximately 10 percent of the programs pharmacy expenditures
Mioduchoski, FNP-BC Medical Weight Loss, Wellness & Peptide Therapy Last Updated: July 2026 Information is reviewed regularly to reflect current insurance policies, Medicare guidance, physician-reviewed treatment recommendations, and clinical best practices
In fact, studies have found that combining HRT and GLP-1s results in 35% more weight loss
December 2025: On December 15, 2025, the U.S